One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.
IL-17
IL-22
alcohol use disorder
alcohol-associated hepatitis
audit
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
04
2023
accepted:
30
11
2023
medline:
3
1
2024
pubmed:
2
1
2024
entrez:
1
1
2024
Statut:
epublish
Résumé
Changes in the expression of cyto- and chemokines due to alcohol-associated liver disease (ALD) have been reported to be both protective and pathogenic. This study examined plasma levels of two key cytokines, Il-17 and Il-22, which construct the proinflammatory vs. anti-inflammatory axes across the spectrum of alcohol use disorder (AUD) and ALD including alcohol-associated hepatitis (AH) to determine the underlying status of the inflammation. Forty-two males and females aged 25-63 yrs. were grouped as healthy controls (HV[n=8]), AUD with no liver injury (AUDNLI [n=8]), AUD with liver injury (AUDLI [n=8]), non-severe alcohol-associated hepatitis (NSAH [n=9]), and severe alcohol-associated hepatitis (SAH [n=9]). Demographic, drinking, and clinical data were collected. Blood samples were collected at baseline (BL, all subjects) and during week 4 (W4, only patients) for IL-17 and IL-22; and statistically analyzed. IL-17 was highly elevated in the SAH group both at BL and post-SOC. LTDH and BL IL-22 in non-severe AH patients were associated significantly. LTDH significantly predicted W4 IL-22 levels, positively (increasing) in NSAH and inversely (lowering) in SAH patients. BL and W4 IL-22 levels were significantly higher (4-fold, p≤0.001) in all AH patients compared to all AUD patients (AUROC=0.988, p≤0.001). IL-22 showed significant affinity with AST, AST: ALT ratio, total bilirubin, INR, and PT both at BL and W4. IL-22 was inversely associated with IL-1β; and positively with TNF-α and IL-8 both at BL, and W4. BL IL-17 showed a positive correlation with MELD (p=0.017) in all AH patients. In SAH, > 2-fold W4 IL-17 level compared to BL showed significant within subjects' effects, p=0.006. In AUD patients without AH, the drop in IL-17 at W4 vs. BL showed a significant within subjects' effect, p=0.031. Drinking chronicity predicted opposite effects in IL-22 levels in NSAH (antiinflammatory) and SAH (pro-inflammatory) patients at post-SOC. BL IL-22 levels differentiated AH patients robustly from the AUD patients (with or without liver injury); and showed corresponding increases stepwise with the stages of ALD. IL-22 was closely associated with progression and injury markers of the liver; and response to the cytokines of pro-inflammatory nature. Pro-inflammatory indicator of IL-17 cell axis, IL-17 showed a strong positive association with MELD, a severity indicator of AH.
Identifiants
pubmed: 38162671
doi: 10.3389/fimmu.2023.1202267
pmc: PMC10755956
doi:
Substances chimiques
Cytokines
0
Interleukin-17
0
Interleukin-22
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1202267Subventions
Organisme : NIAAA NIH HHS
ID : K23 AA029198
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA024337
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 AA999999
Pays : United States
Informations de copyright
Copyright © 2023 Sagaram, Frimodig, Jayanty, Hu, Royer, Bruner, Kong, Schwandt and Vatsalya.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Stud Alcohol Drugs. 2020 Mar;81(2):212-219
pubmed: 32359051
Cells. 2020 Feb 25;9(3):
pubmed: 32106390
J Hepatol. 2013 Sep;59(3):583-94
pubmed: 23567086
Hepatol Commun. 2019 May 10;3(7):867-882
pubmed: 31334440
BMC Microbiol. 2014 Sep 16;14:240
pubmed: 25223989
Clin Exp Pharmacol. 2021;11(Suppl 7):
pubmed: 34522469
Gastroenterology. 2016 Apr;150(4):785-90
pubmed: 26921783
Sci Signal. 2016 Sep 27;9(447):ra95
pubmed: 27678220
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
World J Gastroenterol. 2010 Mar 21;16(11):1321-9
pubmed: 20238398
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
Gastroenterology. 2011 Nov;141(5):1572-85
pubmed: 21920463
Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1019-28
pubmed: 17204547
Hepatology. 2004 May;39(5):1332-42
pubmed: 15122762
J Immunol. 2014 Sep 1;193(5):2512-8
pubmed: 25063867
J Korean Med Sci. 2009 Oct;24(5):941-4
pubmed: 19794996
Przegl Lek. 2006;63(5):249-52
pubmed: 17036498
Alcohol Clin Exp Res. 2001 Apr;25(4):579-89
pubmed: 11329499
Nat Immunol. 2005 Nov;6(11):1133-41
pubmed: 16200068
Liver Int. 2019 Jun;39(6):1062-1070
pubmed: 30506912
J Gastrointestin Liver Dis. 2017 Sep;26(3):269-274
pubmed: 28922439
Alcohol Alcohol. 2020 Mar 19;55(2):164-170
pubmed: 32047901
Clin Transl Gastroenterol. 2020 Aug;11(8):e00197
pubmed: 32955203
Clin Exp Immunol. 1991 Jun;84(3):449-53
pubmed: 2044224
Hepatology. 2001 Jul;34(1):101-8
pubmed: 11431739
Cell Mol Immunol. 2019 May;16(5):473-482
pubmed: 29670279
J Stud Alcohol. 1982 Nov;43(11):1157-70
pubmed: 7182675
Gastroenterol Res Pract. 2010;2010:
pubmed: 20827314
Biomedicines. 2020 Dec 24;9(1):
pubmed: 33374263
Alcohol Clin Exp Res. 2016 Oct;40(10):2085-2093
pubmed: 27589090
Cell Mol Immunol. 2004 Feb;1(1):43-9
pubmed: 16212920
PLoS One. 2013;8(1):e55101
pubmed: 23372820
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2046-2054
pubmed: 31811953
Alcohol Res. 2022 Jan 13;42(1):02
pubmed: 35083099
Gut. 2015 Dec;64(12):1839-40
pubmed: 25841240
Hepatology. 2020 Jan;71(1):306-333
pubmed: 31314133
Nature. 2006 May 11;441(7090):231-4
pubmed: 16648837
Biol Psychiatry. 2014 Nov 1;76(9):725-33
pubmed: 24629538
Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G74-80
pubmed: 19875704
J Hepatol. 2020 Apr;72(4):736-745
pubmed: 31786256
Clin Liver Dis. 2012 Nov;16(4):667-85
pubmed: 23101976
Addict Biol. 2018 Jan;23(1):493-502
pubmed: 27860050
Gut. 2015 Dec;64(12):1949-60
pubmed: 25731872
PLoS One. 2013;8(1):e53028
pubmed: 23326376
Hepatol Commun. 2019 Jan 17;3(3):392-405
pubmed: 30859151
Hepatology. 2009 Feb;49(2):646-57
pubmed: 19177575
J Immunol. 2017 Dec 15;199(12):4078-4090
pubmed: 29109123
Nature. 2007 Feb 8;445(7128):648-51
pubmed: 17187052